EUVIMEDEUVIMED entdecken
Crossref

Berberine derivative C51 modulates cGAS-STING-TIM-3 axis to reverse immune evasion and inhibit lung cancer growth

Yuyan Bao, Bing Hong, Kaiping Liu, Zhenjian Lin, Jie Zhou, Yaping Wu, Senfeng Mou, Yanjie Yu

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2025.112258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Yuyan Bao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Preparation Section, Sanmen People's Hospital, Sanmen County, Zhejiang Province 317100, China. Electronic address: baoyuyan@zjsmyy.com. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Berberine, Membrane Proteins, Lung Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Berberine, also known as berberine hydrochloride, is an isoquinoline alkaloid extracted from natural plants, exhibiting a wide range of biological activities, including anti-inflammatory, antioxidant, antitumor, antibacterial, antiviral, and neuroprotective effects. However, its low oral absorption rate and poor bioavailability limit its clinical application. To address this issue, this study synthesized a novel Berberine derivative, C51, which significantly improves absorption rate and bioavailability while enhancing its antitumor activity. This study focused on the antitumor mechanism of C51 in lung cancer, particularly its ability to inhibit lung cancer cell proliferation, invasion, and migration by regulating the cGAS (Cyclic GMP-AMP Synthase)-STING (Transmembrane Protein 173) -TIM-3 (T-cell Immunoglobulin and Mucin Domain-containing Molecule 3) molecular axis. Experimental results demonstrated that C51 significantly inhibited lung cancer cell proliferation at very low concentrations, with its half-maximal inhibitory concentration (IC50) significantly lower than that of Berberine. Additionally, C51 exerted its antitumor effects by activating the cGAS-STING molecular axis and inhibiting the TIM-3 molecular axis. Silencing TIM-3 inhibits the proliferation and immune escape of lung cancer. Further molecular mechanism studies revealed that CGAS directly regulates the STING-TIM-3 molecular axis, while STING forms a chaperone relationship with TIM-3 and promotes TIM-3 degradation through the K48-dependent ubiquitination pathway, thereby suppressing the malignant phenotype of lung cancer cells. These findings not only reveal the antitumor mechanism of C51 but also provide new insights for the treatment of lung cancer. Animal experiments also demonstrated that C51 significantly inhibits the proliferation of subcutaneous xenograft tumors in mouse. As a novel Berberine derivative, C51 exhibits significant antitumor activity and inhibits lung cancer progression by regulating the CGAS-STING-TIM-3 molecular axis. This study lays an important theoretical foundation for the development of novel antitumor drugs based on C51, with significant clinical application potential. However, the long-term toxicity and safety of C51 require further investigation to establish safe dosage standards for clinical use. Future studies will focus on exploring combination therapy strategies of C51 in cisplatin-resistant lung cancer to provide new directions for precision treatment of lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleotidyltransferasesBerberineMembrane ProteinsLung NeoplasmsHepatitis A Virus Cellular Receptor 2Immune EvasionHumansAnimalsCell ProliferationMiceCell Line, TumorSignal TransductionMice, Inbred BALB CA549 CellsMice, NudeSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

Berberine derivative C51ProliferationSTINGTIM-3cGAS

Substanzen

NucleotidyltransferasesBerberineMembrane ProteinscGAS protein, humanSTING1 protein, humanHepatitis A Virus Cellular Receptor 2HAVCR2 protein, humanSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Pharmaceutical Preparation Section, Sanmen People's Hospital, Sanmen County, Zhejiang Province 317100, China. Electronic address: baoyuyan@zjsmyy.com.
  • Pharmaceutical Preparation Section, Sanmen People's Hospital, Sanmen County, Zhejiang Province 317100, China.
  • Sanmen Market Supervisory Authority, Sanmen County, Zhejiang Province 317100, China.

Förderung

  • Science and Technology Department of Zhejiang Province

Zitieren

APA

Bao, Y., Hong, B., Liu, K., Lin, Z., Zhou, J., Wu, Y., Mou, S., & Yu, Y. (2026). Berberine derivative C51 modulates cGAS-STING-TIM-3 axis to reverse immune evasion and inhibit lung cancer growth. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112258

Vancouver

Bao Y, Hong B, Liu K, Lin Z, Zhou J, Wu Y, et al. Berberine derivative C51 modulates cGAS-STING-TIM-3 axis to reverse immune evasion and inhibit lung cancer growth. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112258

BibTeX
@article{Bao2026,
  author = {Bao, Yuyan and Hong, Bing and Liu, Kaiping and Lin, Zhenjian and Zhou, Jie and Wu, Yaping and Mou, Senfeng and Yu, Yanjie},
  title = {Berberine derivative C51 modulates cGAS-STING-TIM-3 axis to reverse immune evasion and inhibit lung cancer growth},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2025.112258}
}
Kostenlos starten →